You are here: Industry Insights > Commercialization

News List

Pharmaceutical Business in China and Worldwide (October)(2023) PharmaSources
November 01, 2023
Pharmaceutical companies sign cooperation agreements with research laboratories to provide commercialization of drug products.
Pulmatrix Enters Into Binding Term Sheet with Cipla Technologies LLC for the Development and Commercialization of Pulmazole pharmafocusasia
April 03, 2019
Pulmatrix, Inc., a clinical stage biopharmaceutical company focused on developing novel inhaled therapeutics to serve unmet needs in respiratory disease, announced today its entry into a Binding Term Sheet with Cipla Technologies LLC ("Cip Tec")...
Amarantus Announces Commercialization Partnership With IDEA Pharma for Subsidiaries firstwordpharma
January 13, 2019
IDEA, who have supported 8 of the 15 biggest biopharmaceutical launches in the past 3 years, will partner with Amarantus in a novel royalty-split model.
Amarantus Announces Commercialization Partnership With IDEA Pharma for Subsidiaries firstwordpharma
January 13, 2019
IDEA, who have supported 8 of the 15 biggest biopharmaceutical launches in the past 3 years, will partner with Amarantus in a novel royalty-split model.
Sandoz Enters Into Commercialization, Supply Agreement for Insulin Biosimilars americanpharmaceuticalreview
December 20, 2018
Sandoz has entered into an agreement to commercialize biosimilar versions of insulins used in patients with type 1 and type 2 diabetes.....
Evolus Receives Conditional FDA Acceptance of Jeuveau Brand Name drugs
December 05, 2018
Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced the conditional acceptance from the U.S. Food and Drug Administration (“FDA”) of the Jeuveau™ brand name .....
Merck Brings Customers Closer to Gene Therapy Product Commercialization prnasia
October 19, 2017
Merck, a leading science and technology company, today announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance® viral and gene therapy products has completed both a U.S.